CXCL10 and diabetes mellitus: Schulthess et al. found that IP-10 impairs β cell function via TLR4 signaling in patients with type 2 diabetes29, and Morimoto et al. demonstrated that IP-10 neutralization enhanced β cell proliferation and suppressed diabetes occurrence in non-obese diabetic mice31.